Furthermore, HSBP1 can shield myofibrils from degradation by binding to them and stabilize sarcomeric proteins, indicating that HSBP1 induction is a potential target to reverse AF-induced cardiac remodeling [44]. The gene discussed is HSBP1; the disease is atrial fibrillation.